AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33165249 — intervention group
Group type: COMPARATOR
Intervention: Control group treatment with debridement, local anesthesia, and suture technique without medical adhesive
Number of subjects: 180
Study 35421491 — intervention group
Group type: EXPERIMENTAL
Intervention: Poultry management training program
Number of subjects: 609
Study 32748649 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily/near-daily cannabis use
Number of subjects: 119
Study 32748649 — intervention group
Group type: COMPARATOR
Intervention: No cannabis use
Number of subjects: 119
Study 32748649 — intervention group
Group type: EXPERIMENTAL
Intervention: Less-frequent cannabis use
Number of subjects: 119
Study 36130180 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily positive events reported on 83% of days
Number of subjects: 200
Study 36130180 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily negative events reported on 56% of days
Number of subjects: 200
Study 36130180 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 200
Study 36130180 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse childhood experiences (ACEs)
Number of subjects: 200
Study 34217029 — intervention group
Group type: EXPERIMENTAL
Intervention: Start-Up NurseS program (4 weeks duration)
Number of subjects: 67
Study 34217029 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 67
Study 32195930 — intervention group
Group type: EXPERIMENTAL
Intervention: SWJQD combined with acupuncture
Number of subjects: 81
Study 32195930 — intervention group
Group type: COMPARATOR
Intervention: SWJQD combined with sham acupuncture
Number of subjects: 81
Study 32195930 — intervention group
Group type: COMPARATOR
Intervention: metformin
Number of subjects: 81
Study 35507047 — intervention group
Group type: EXPERIMENTAL
Intervention: CSP with EverLift™
Number of subjects: 291
Study 35507047 — intervention group
Group type: COMPARATOR
Intervention: CSP without EverLift™
Number of subjects: 291
Study 32776101 — intervention group
Group type: EXPERIMENTAL
Intervention: glo THP
Number of subjects: 0
Study 32776101 — intervention group
Group type: COMPARATOR
Intervention: Smoking cessation
Number of subjects: 0
Study 32776101 — intervention group
Group type: COMPARATOR
Intervention: Never-smokers
Number of subjects: 0
Study 32776101 — intervention group
Group type: COMPARATOR
Intervention: Continued smoking
Number of subjects: 0
Study 33955250 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment plus proprioceptive training program
Number of subjects: 12
Study 33955250 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (control group)
Number of subjects: 12
Study 616848737 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise program (HEP) using a motion capture gerontechnology for 12 weeks
Number of subjects: 16
Study 616848737 — intervention group
Group type: COMPARATOR
Intervention: Control group (CONTR) continuing with discharge plan from ED
Number of subjects: 16
Study 616848737 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise program (HEP)
Number of subjects: 16
Study 35429293 — intervention group
Group type: EXPERIMENTAL
Intervention: Watermelon juice concentrate (WM; 2.2 g·day‐1 L‐citrulline)
Number of subjects: 15
Study 35429293 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 15
Study 34078638 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) for 12 weeks
Number of subjects: 72
Study 34078638 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 72
Study 35715774 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate sodium plus vitamin D3
Number of subjects: 60
Study 35715774 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 32592568 — intervention group
Group type: EXPERIMENTAL
Intervention: General hydrogalvanic baths
Number of subjects: 84
Study 32592568 — intervention group
Group type: COMPARATOR
Intervention: Drug treatment (NSAIDs, muscle relaxants, anticonvulsants)
Number of subjects: 84
Study 35942522 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesalazine 2400 mg once-daily for 8 weeks
Number of subjects: 181
Study 35942522 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 181
Study 35942522 — intervention group
Group type: EXPERIMENTAL
Intervention: Meta-analysis of mesalazine
Number of subjects: 181
Study 35942522 — intervention group
Group type: EXPERIMENTAL
Intervention: Mucosal patch technology measures
Number of subjects: 181
Study 33742604 — intervention group
Group type: EXPERIMENTAL
Intervention: SPEM curriculum (experimental group)
Number of subjects: 3734
Study 33742604 — intervention group
Group type: COMPARATOR
Intervention: Comparison curriculum (control group)
Number of subjects: 3734
Study 36004652 — intervention group
Group type: EXPERIMENTAL
Intervention: Finerenone
Number of subjects: 0
Study 36004652 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32155470 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindlight (experimental condition)
Number of subjects: 109
Study 32155470 — intervention group
Group type: COMPARATOR
Intervention: Triple Town (control condition)
Number of subjects: 109
Study 32049691 — intervention group
Group type: EXPERIMENTAL
Intervention: PCD-CT VMIs at 50 keV
Number of subjects: 0
Study 32049691 — intervention group
Group type: EXPERIMENTAL
Intervention: DE VMIs
Number of subjects: 0
Study 32049691 — intervention group
Group type: COMPARATOR
Intervention: SE images
Number of subjects: 0
Study 32049691 — intervention group
Group type: EXPERIMENTAL
Intervention: PCD-CT
Number of subjects: 0
Study 32049691 — intervention group
Group type: COMPARATOR
Intervention: SE
Number of subjects: 0
Study 32049691 — intervention group
Group type: EXPERIMENTAL
Intervention: DE
Number of subjects: 0
Study 36032032 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-incision intra-articular injection of 10 mL ropivacaine with epinephrine and 20 mL post-arthrotomy peri-articular injection (PAI)
Number of subjects: 41
Study 36032032 — intervention group
Group type: COMPARATOR
Intervention: Standard 30 mL post-arthrotomy PAI of ropivacaine with epinephrine
Number of subjects: 41
Study 34416469 — intervention group
Group type: EXPERIMENTAL
Intervention: Panitumumab plus FOLFOX followed by panitumumab-based maintenance
Number of subjects: 0
Study 36059939 — intervention group
Group type: EXPERIMENTAL
Intervention: Leuprolide acetate microspheres 3.75 mg (T)
Number of subjects: 48
Study 36059939 — intervention group
Group type: COMPARATOR
Intervention: Enantone® 3.75 mg (R)
Number of subjects: 48
Study 32833578 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and Root Planing with Photobiomodulation (PBMT)
Number of subjects: 0
Study 32833578 — intervention group
Group type: COMPARATOR
Intervention: Scaling and Root Planing (SRP) without PBMT (Control)
Number of subjects: 0
Study 32833578 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (SRP with PBMT and SRP without PBMT)
Number of subjects: 0
Study 616897251 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat application (2 minutes under servo-controlled mode at 35.5°C, followed by 2 minutes in manual mode at 100% power)
Number of subjects: 40
Study 616897251 — intervention group
Group type: COMPARATOR
Intervention: Control group (radiant warmer at 35.5°C for 4 minutes)
Number of subjects: 40
Study 34022474 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Remediation + Exercise (CR + E)
Number of subjects: 34
Study 34022474 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Remediation Only (CR-Only)
Number of subjects: 34
Study 32534921 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal colostrum (MC)
Number of subjects: 44
Study 32534921 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-quality maternal colostrum supplemented with colostrum replacer (CR)
Number of subjects: 44
Study 32534921 — intervention group
Group type: EXPERIMENTAL
Intervention: Colostrum replacer (CR) with distinct levels of IgG concentration
Number of subjects: 44
Study 34264737 — intervention group
Group type: EXPERIMENTAL
Intervention: Harm-reduction treatment for alcohol use disorder (AUD)
Number of subjects: 294
Study 32645160 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender-affirming treatment
Number of subjects: 7770
Study 32645160 — intervention group
Group type: COMPARATOR
Intervention: Other groups (not receiving gender-affirming treatment)
Number of subjects: 7770
Study 37166567 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 μg ID93 + 5 μg GLA-SE
Number of subjects: 107
Study 37166567 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 μg ID93 + 5 μg GLA-SE
Number of subjects: 107
Study 37166567 — intervention group
Group type: COMPARATOR
Intervention: 0.9% normal saline placebo
Number of subjects: 107
Study 34219013 — intervention group
Group type: EXPERIMENTAL
Intervention: Body pillow position (group B)
Number of subjects: 85
Study 34219013 — intervention group
Group type: COMPARATOR
Intervention: Previous position using the arm fixation device (group A)
Number of subjects: 85
Study 34219013 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 85
Study 32004636 — intervention group
Group type: EXPERIMENTAL
Intervention: OLZ/SAM (10/10 mg on days 2-4, 20/20 mg on days 5-8, 30/30 mg on days 9-13)
Number of subjects: 100
Study 32004636 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin (400 mg)
Number of subjects: 100
Study 32004636 — intervention group
Group type: EXPERIMENTAL
Intervention: OLZ/SAM (all doses)
Number of subjects: 100
Study 35914240 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction
Number of subjects: 0
Study 35914240 — intervention group
Group type: COMPARATOR
Intervention: Expectant Management
Number of subjects: 0
Study 32691466 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton Pump Inhibitor (PPI) treatment
Number of subjects: 0
Study 32691466 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-reflux surgery
Number of subjects: 0
Study 32691466 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical therapy (including H2 receptor antagonists, alginates, baclofen, antidepressants)
Number of subjects: 0
Study 32691466 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic techniques
Number of subjects: 0
Study 32353962 — intervention group
Group type: EXPERIMENTAL
Intervention: MgCl2 (ReMag®, 300 mg)
Number of subjects: 17
Study 32353962 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 35067237 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary treatment for weight loss
Number of subjects: 68
Study 35067237 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise treatment
Number of subjects: 68
Study 35067237 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 68
Study 35067237 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 68
Study 34011587 — intervention group
Group type: EXPERIMENTAL
Intervention: Home management
Number of subjects: 203
Study 34011587 — intervention group
Group type: COMPARATOR
Intervention: Hospital management
Number of subjects: 203
Study 32168423 — intervention group
Group type: EXPERIMENTAL
Intervention: sST2-guided treatment (known sST2 level)
Number of subjects: 123
Study 32168423 — intervention group
Group type: COMPARATOR
Intervention: Usual treatment (unknown sST2 level)
Number of subjects: 123
Study 36197251 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological responses intervention (not specified in detail)
Number of subjects: 142
Study 33718262 — intervention group
Group type: EXPERIMENTAL
Intervention: MLMA assay for identifying V. parahaemolyticus 57 K-serogroups
Number of subjects: 595
Study 33718262 — intervention group
Group type: EXPERIMENTAL
Intervention: MLMA assay
Number of subjects: 595
Study 33718262 — intervention group
Group type: COMPARATOR
Intervention: Traditional serotyping methods
Number of subjects: 595
Study 32406009 — intervention group
Group type: EXPERIMENTAL
Intervention: TJ-28 (7500 mg/day)
Number of subjects: 22
Study 32406009 — intervention group
Group type: COMPARATOR
Intervention: Pyridoxine (60 mg/day)
Number of subjects: 22
Study 34606954 — intervention group
Group type: EXPERIMENTAL
Intervention: TAAA repair
Number of subjects: 664
Study 34606954 — intervention group
Group type: COMPARATOR
Intervention: Control population (without TAAAs)
Number of subjects: 664
Study 34606954 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 664
Study 34606954 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral artery disease
Number of subjects: 664
Study 34606954 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 664
Study 34606954 — intervention group
Group type: EXPERIMENTAL
Intervention: Congestive heart failure
Number of subjects: 664
Study 34606954 — intervention group
Group type: EXPERIMENTAL
Intervention: Urgent procedures
Number of subjects: 664
Study 34606954 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous coronary revascularization
Number of subjects: 664
Study 34606954 — intervention group
Group type: EXPERIMENTAL
Intervention: High-volume institutions (>60 TAAA repairs)
Number of subjects: 664
Study 34606954 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age, chronic kidney disease, congestive heart failure, urgent procedures
Number of subjects: 664
Study 34606954 — intervention group
Group type: EXPERIMENTAL
Intervention: Type of repair (endovascular vs open)
Number of subjects: 664
Study 34014249 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthracycline group (3 cycles of fluorouracil, epirubicin, and cyclophosphamide followed by 6 cycles of paclitaxel and carboplatin)
Number of subjects: 438
Study 34014249 — intervention group
Group type: COMPARATOR
Intervention: Non-anthracycline group (9 cycles of paclitaxel and carboplatin)
Number of subjects: 438
Study 34014249 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthracycline group
Number of subjects: 438
Study 34014249 — intervention group
Group type: COMPARATOR
Intervention: Non-anthracycline group
Number of subjects: 438
Study 32763872 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrist-worn Fitbit Flex and app, weekly challenges, digital behavior change resources, email or text message alerts
Number of subjects: 144
Study 32763872 — intervention group
Group type: EXPERIMENTAL
Intervention: Text messages
Number of subjects: 144
Study 32763872 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly challenges
Number of subjects: 144
Study 32763872 — intervention group
Group type: EXPERIMENTAL
Intervention: Facebook videos
Number of subjects: 144
Study 32763872 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitbit Flex
Number of subjects: 144
Study 32763872 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based delivery
Number of subjects: 144
Study 32763872 — intervention group
Group type: EXPERIMENTAL
Intervention: Facebook engagement
Number of subjects: 144
Study 35329366 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental Outdoor (EO) intervention
Number of subjects: 106
Study 35329366 — intervention group
Group type: COMPARATOR
Intervention: Traditional Indoor (TI) intervention
Number of subjects: 106
Study 35942877 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD implantation
Number of subjects: 1116
Study 35942877 — intervention group
Group type: COMPARATOR
Intervention: Usual clinical care
Number of subjects: 1116
Study 34652717 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane Block (ESPB)
Number of subjects: 62
Study 34652717 — intervention group
Group type: COMPARATOR
Intervention: Oblique Subcostal Transverse Abdominis Plane Block (TAPB)
Number of subjects: 62
Study 35020056 — intervention group
Group type: EXPERIMENTAL
Intervention: Scheduled second look endoscopy (SLOGD)
Number of subjects: 157
Study 35020056 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 157
Study 32744208 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly projections
Number of subjects: 0
Study 32744208 — intervention group
Group type: EXPERIMENTAL
Intervention: Quarterly projections
Number of subjects: 0
Study 32744208 — intervention group
Group type: EXPERIMENTAL
Intervention: Semiannual projections
Number of subjects: 0
Study 32744208 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual projections
Number of subjects: 0
Study 32744208 — intervention group
Group type: EXPERIMENTAL
Intervention: REACH-based probabilities
Number of subjects: 0
Study 32744208 — intervention group
Group type: EXPERIMENTAL
Intervention: USA life table probabilities
Number of subjects: 0
Study 32744208 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-a-cycle age correction
Number of subjects: 0
Study 32744208 — intervention group
Group type: EXPERIMENTAL
Intervention: No half-a-cycle age correction
Number of subjects: 0
Study 32052216 — intervention group
Group type: EXPERIMENTAL
Intervention: Goff septotomy
Number of subjects: 7984
Study 32052216 — intervention group
Group type: COMPARATOR
Intervention: Control index ERCPs
Number of subjects: 7984
Study 32052216 — intervention group
Group type: EXPERIMENTAL
Intervention: Double wire technique
Number of subjects: 7984
Study 32052216 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle knife precut
Number of subjects: 7984
Study 32097622 — intervention group
Group type: EXPERIMENTAL
Intervention: Monte Carlo simulations
Number of subjects: 0
Study 34144370 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram and risk matrix for predicting suicide risk
Number of subjects: 112372
Study 34144370 — intervention group
Group type: EXPERIMENTAL
Intervention: Cox proportional hazard models
Number of subjects: 112372
Study 32651587 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural Anesthesia (EA)
Number of subjects: 110
Study 32651587 — intervention group
Group type: COMPARATOR
Intervention: Control (no EA)
Number of subjects: 110
Study 35617826 — intervention group
Group type: EXPERIMENTAL
Intervention: AZ/BNT
Number of subjects: 254
Study 35617826 — intervention group
Group type: EXPERIMENTAL
Intervention: BNT/BNT
Number of subjects: 254
Study 35617826 — intervention group
Group type: COMPARATOR
Intervention: AZ/AZ
Number of subjects: 254
Study 35753883 — intervention group
Group type: EXPERIMENTAL
Intervention: Chiropractic spinal manipulation (CSM) and exercise
Number of subjects: 176
Study 36303476 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic-impregnated catheter
Number of subjects: 1594
Study 36303476 — intervention group
Group type: COMPARATOR
Intervention: Standard catheter (control)
Number of subjects: 1594
Study 36303476 — intervention group
Group type: EXPERIMENTAL
Intervention: Age < 1 month
Number of subjects: 1594
Study 36303476 — intervention group
Group type: EXPERIMENTAL
Intervention: Age 1 month to < 1 year
Number of subjects: 1594
Study 36303476 — intervention group
Group type: EXPERIMENTAL
Intervention: Age ≥ 65 years
Number of subjects: 1594
Study 36064444 — intervention group
Group type: EXPERIMENTAL
Intervention: Trans-theoretical-based behavioral intervention package
Number of subjects: 360
Study 36064444 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 360
Study 32875913 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral nutrition (TP‐MCT) in addition to the regular diet
Number of subjects: 0
Study 32470703 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin implant @ 18mg/50 kg B.Wt
Number of subjects: 12
Study 32470703 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 12
Study 33808180 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean Diet (MedDiet)
Number of subjects: 19
Study 33808180 — intervention group
Group type: COMPARATOR
Intervention: Usual diet
Number of subjects: 19
Study 34049869 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive web-based learning module on medication safety
Number of subjects: 16
Study 34049869 — intervention group
Group type: COMPARATOR
Intervention: Five articles to read about medication safety (Control)
Number of subjects: 16
Study 32333510 — intervention group
Group type: EXPERIMENTAL
Intervention: QR678 therapy
Number of subjects: 50
Study 32333510 — intervention group
Group type: COMPARATOR
Intervention: PRP
Number of subjects: 50
Study 35279105 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous rhEPO (10,000 IU daily from 5 days preoperatively to 3 days postoperatively)
Number of subjects: 180
Study 35279105 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous normal saline (1 ml daily from 5 days preoperatively to 3 days preoperatively) followed by rhEPO (10,000 IU daily until 3 days postoperatively)
Number of subjects: 180
Study 35279105 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous normal saline (1 ml daily from 5 days preoperatively to 1 day preoperatively) followed by rhEPO (10,000 IU daily from the day of surgery to 3 days postoperatively)
Number of subjects: 180
Study 35279105 — intervention group
Group type: COMPARATOR
Intervention: All groups (A, B, C)
Number of subjects: 180
Study 35279105 — intervention group
Group type: COMPARATOR
Intervention: Group C
Number of subjects: 180
Study 34047297 — intervention group
Group type: EXPERIMENTAL
Intervention: TotalFill BC Sealer (TFBCS) soaked in simulated body fluid (SBF) for one day
Number of subjects: 60
Study 34047297 — intervention group
Group type: EXPERIMENTAL
Intervention: TotalFill BC Sealer (TFBCS) soaked in simulated body fluid (SBF) for one week
Number of subjects: 60
Study 34047297 — intervention group
Group type: EXPERIMENTAL
Intervention: TotalFill BC Sealer (TFBCS) soaked in simulated body fluid (SBF) for two months
Number of subjects: 60
Study 34047297 — intervention group
Group type: COMPARATOR
Intervention: MTA Fillapex (MTAFS) soaked in simulated body fluid (SBF) for one day
Number of subjects: 60
Study 34047297 — intervention group
Group type: EXPERIMENTAL
Intervention: MTA Fillapex (MTAFS) soaked in simulated body fluid (SBF) for one week
Number of subjects: 60
Study 34047297 — intervention group
Group type: EXPERIMENTAL
Intervention: MTA Fillapex (MTAFS) soaked in simulated body fluid (SBF) for two months
Number of subjects: 60
Study 32485328 — intervention group
Group type: EXPERIMENTAL
Intervention: argatroban plus r‐tPA
Number of subjects: 808
Study 32485328 — intervention group
Group type: COMPARATOR
Intervention: r‐tPA alone
Number of subjects: 808
Study 35018724 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulation tissue preservation technique (GTPT)
Number of subjects: 40
Study 35018724 — intervention group
Group type: COMPARATOR
Intervention: Double-flap approach with resection of the defect-filling granulation tissue (control group)
Number of subjects: 40
Study 33720651 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinupret (herbal medicine in oral drops)
Number of subjects: 107
Study 33720651 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 107